Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 9.
doi: 10.1007/s00586-025-09378-8. Online ahead of print.

Answer to the Letter to the Editor of A. Bilge, et al. concerning "Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients" by Narayanan R, Dalton J, A McCurdy M, et al. (Eur Spine J [2025] doi:10.1007/s00586-025-08764-6)

Rajkishen Narayanan  1 , Jonathan Dalton  2   3 , Gregorio Baek  1 , Michael A McCurdy  1 , Tariq Z Issa  1 , Robert J Oris  1 , Alexa Tomlak  1 , Yunsoo Lee  1 , Kenneth McCall  1 , Dodger Norceide  1 , John J Mangan  1 , Mark F Kurd  1 , Ian David Kaye  1 , Jose A Canseco  1 , Alan S Hilibrand  1 , Alexander R Vaccaro  1 , Christopher K Kepler  1 , Gregory D Schroeder  1
Affiliations

Answer to the Letter to the Editor of A. Bilge, et al. concerning "Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients" by Narayanan R, Dalton J, A McCurdy M, et al. (Eur Spine J [2025] doi:10.1007/s00586-025-08764-6)

Rajkishen Narayanan et al. Eur Spine J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing Interests: No potential conflict of interest relevant to this article. The authors, their immediate family, and any research foundation with which they are affiliated did not receive any financial payments or other benefits from any commercial entity related to the subject of this article. There are no relevant disclosures. The authors have no potential conflict of interest to disclose relevant to the submitted work. Ethical Approval and Participant Consent: This is an IRB-approved retrospective study (approval #19D.508). All patient information was de-identified and patient consent was not required. Patient data will not be shared with third parties. This research was conducted without any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. All data utilized in this study were sourced from institutional records. The authors have no funding to disclose relevant to the submitted work. Drug Statement: The drug(s) mentioned in this study is FDA-approved or approved by corresponding national agency for this indication.

References

    1. Kiang MV, Basu S, Chen J, Alexander MJ (2019) Assessment of changes in the geographical distribution of opioid-Related mortality across the united States by opioid type, 1999–2016. JAMA Netw Open 2(2):e190040. https://doi.org/10.1001/jamanetworkopen.2019.0040 - DOI - PubMed - PMC
    1. Volkow ND, Blanco C (2021) The changing opioid crisis: development, challenges and opportunities. Mol Psychiatry 26(1):218–233. https://doi.org/10.1038/s41380-020-0661-4 - DOI - PubMed
    1. Cushnie D, Soroceanu A, Stratton A et al (2022) Outcome of spine surgery in patients with depressed mental states: a Canadian spine outcome research network study. Spine J 22(10):1700–1707. https://doi.org/10.1016/j.spinee.2022.05.012 - DOI - PubMed
    1. Javeed S, Benedict B, Yakdan S et al (2024) Implications of preoperative depression for lumbar spine surgery outcomes: A systematic review and Meta-Analysis. JAMA Netw Open 7(1):e2348565. https://doi.org/10.1001/jamanetworkopen.2023.48565 - DOI - PubMed - PMC
    1. Deyo RA, Von Korff M, Duhrkoop D (2015) Opioids for low back pain. BMJ 350:g6380. https://doi.org/10.1136/bmj.g6380 - DOI - PubMed - PMC

LinkOut - more resources